Biosynex SA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 196.6 million compared to EUR 382.5 million a year ago. Net income was EUR 15.6 million compared to EUR 104 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 EUR | -9.52% | -14.54% | -65.87% |
28/05 | Biosynex: obtains CE markings under the new IVDR regulations | CF |
13/05 | Biosynex: Oren Bitton appointed Chief Operating Officer | CF |
1st Jan change | Capi. | |
---|---|---|
-65.87% | 36.29M | |
-11.28% | 11.41B | |
-12.48% | 7.4B | |
+29.86% | 5.64B | |
-0.60% | 5.33B | |
-19.19% | 3.7B | |
+7.43% | 2.58B | |
-64.80% | 2.38B | |
-10.84% | 2.2B | |
+26.21% | 2.2B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2022